Guyās and St Thomasā IT platform prioritises āhidden riskā diabetes patients
An IT platform developed at Guyās and St Thomasā can identify high risk diabetes patients, enabling them to be prioritised for urgent care.
Back to Top
An IT platform developed at Guyās and St Thomasā can identify high risk diabetes patients, enabling them to be prioritised for urgent care.
Dr Hatim Abdulhussein and Dr Nadine Hachach-Haram, founder and CEO of ProximieĀ have been confirmed asĀ speakers forĀ Digital Health AI and Data 2023.Ā
Mahana Therapeutics has signed an agreement with Bayer’s Consumer Health division which will see its digital therapeutics commercialised.
According to a new report from Dentaly, 35% of US dentists have already adopted AI technology and many more are open to the idea of doing so.
The latest industry roundup features a refurbished ward at Norfolk and Suffolk NHS FT and a London cancer centre achieving an ‘Outstanding’ CQC rating.
National Data Guardian Nicola Byrne has warned NHSE that it must be fully transparent about the aims and due diligence involved in the tender for the FDP
Healthcare professionals in Oxford are to trial the N-Tidal, a new AI-powered device that can identify patients with chronic obstructive pulmonary disease.
It was named by 78% of those questioned, according to the findings of the 2019
Tara Donnelly confirmed that no patient will be shared with Amazon following an initiative to
The Public Accounts Committee continues to ladle out criticism of an ongoing project to update
NHS prescription reminder and tracking app Echo has been acquired by the owner of LloydsPharmacy.
According to the information released by NHS Digital, the NHSmail system blocked a total of